A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Circulating cell-free DNA level predicts all-cause mortality independent of other predictors in the Health 2000 survey




TekijätL. Kananen, M. Hurme, M. Jylhä, T. Härkänen, S. Koskinen, S. Stenholm, M. Kähönen, T. Lehtimäki, O. Ukkola, J. Jylhävä

KustantajaNATURE RESEARCH

Julkaisuvuosi2020

JournalScientific Reports

Tietokannassa oleva lehden nimiSCIENTIFIC REPORTS

Lehden akronyymiSCI REP-UK

Artikkelin numeroARTN 13809

Vuosikerta10

Numero1

Sivujen määrä9

ISSN2045-2322

eISSN2045-2322

DOIhttps://doi.org/10.1038/s41598-020-70526-9

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/50246661


Tiivistelmä
Increased levels of circulating cell-free DNA (cf-DNA) are associated with and predict poor health outcomes. However, its predictive ability for mortality in population-based samples remains understudied. We analysed the capability of cf-DNA to predict all-cause mortality and assessed whether it adds predictive value on top of the other risk factors in the Health 2000 survey (n = 1,257, 46-76 years of age, 15-years-follow-up, 18% deceased). When analysed in a multivariate model with the other factors that independently predicted mortality in the sample (age, gender, self-rated health, smoking and plasma levels of glucose and adiponectin), increases in cf-DNA levels were associated with increased risk of mortality (hazard ratio [HR] for 0.1 mu g increase in cf-DNA: 1.017, 95% confidence interval [CI] 1.008-1.026, p = 0.0003). Inclusion of cf-DNA in the model improved the model fit and discrimination. Stratifying the analysis by cardiovascular disease (CVD) status indicated that cf-DNA predicted mortality equally well in individuals with (HR 1.018, 95% CI 1.008-1.026, p = 0.002) and without (HR 1.018, 95% CI 1.001-1.035, p = 0.033) CVD. In conclusion, our study indicates that cf-DNA level predicts mortality in middle-aged and older individuals, also among those with established CVD, and adds significant value to mortality prediction. Our results thus underscore the role of cf-DNA as a viable marker of health.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 14:00